Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket

Gainers

Delcath Systems, Inc. DCTH shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma.
Sonim Technologies, Inc. SONM rose 29.1% to $0.71 in pre-market trading after the company reported a 125% revenue increase in the second quarter.
G Medical Innovations Holdings Ltd GMVD shares gained 21% to $0.2299 in pre-market trading after falling over 7% on Monday.
T2 Biosystems, Inc. TTOO shares gained 18.4% to $0.4619 in pre-market trading after jumping 15% on Monday.
The Arena Group Holdings, Inc. AREN shares climbed 18.3% to $4.00 in pre-market trading after the company announced it signed a binding letter of intent to combine with Bridge Media Networks.
LL Flooring Holdings, Inc. LL shares rose 12.5% to $4.22 in pre-market trading after the company’s board announced exploration of strategic alternatives, including a sale.
Castellum, Inc. CTM rose 10.8% to $0.5320 in pre-market trading after posting better-than-expected quarterly sales.
Siyata Mobile Inc. SYTA shares rose 10.8% to $3.68 in pre-market trading following upbeat quarterly sales.
Grove Collaborative Holdings, Inc. GROV gained 10.5% to $2.42 in pre-market trading after the company posted strong quarterly sales and announced leadership changes.
Taysha Gene Therapies, Inc. TSHA gained 9.4% to $2.33 in pre-market trading. Taysha Gene Therapies shares jumped 188% on Monday after the company reported initial clinical data from the first adult Rett Syndrome patient dosed in the REVEAL Phase 1/2 trial and announced $150 million private placement financing.

Losers

F45 Training Holdings Inc. FXLV fell 62.7% to $0.2695 in pre-market trading after the company announced its intent to voluntarily delist and deregister its securities.
Altisource Asset Management Corporation AAMC shares fell 61.3% to $12.72 in pre-market trading after the company posted a wider second-quarter loss.
Alaunos Therapeutics, Inc. TCRT shares fell 49.4% to $0.1993 in pre-market trading after posting a loss for the second quarter.
Design Therapeutics, Inc. DSGN fell 37.9% to $4.55 in pre-market trading after the company reported second-quarter results and announced initial results from Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich Ataxia.
MGO Global, Inc. MGOL fell 32.3% to $1.53 in pre-market trading.
OptimizeRx Corporation OPRX shares fell 22.4% to $9.75 in pre-market trading after posting weak quarterly sales.
TFF Pharmaceuticals, Inc. TFFP fell 22.2% to $0.35 in pre-market trading after the company reported second-quarter results and priced $5 million public offering of common stock.
Aptevo Therapeutics Inc. APVO fell 21.1% to $0.3554 in pre-market trading. Aptevo Therapeutics recently posted a wider-than-expected quarterly loss.
Jet.AI Inc. JTAI fell 18.8% to $4.06 in pre-market after declining 25% on Monday.
Getty Images Holdings, Inc. GETY fell 18.6% to $3.70 in pre-market trading after the company reported second-quarter earnings.